Literature DB >> 32736085

Microglia and astrocyte dysfunction in parkinson's disease.

Tae-In Kam1, Jared T Hinkle2, Ted M Dawson3, Valina L Dawson4.   

Abstract

While glia are essential for regulating the homeostasis in the normal brain, their dysfunction contributes to neurodegeneration in many brain diseases, including Parkinson's disease (PD). Recent studies have identified that PD-associated genes are expressed in glial cells as well as neurons and have crucial roles in microglia and astrocytes. Here, we discuss the role of microglia and astrocytes dysfunction in relation to PD-linked mutations and their implications in PD pathogenesis. A better understanding of microglia and astrocyte functions in PD may provide insights into neurodegeneration and novel therapeutic approaches for PD.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; Glia; Microglia; Neurodegeneration; Neurodegenerative disease; Neuroinflammation; Parkinson's disease

Year:  2020        PMID: 32736085      PMCID: PMC7484088          DOI: 10.1016/j.nbd.2020.105028

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  189 in total

1.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

2.  Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.

Authors:  Aree Witoelar; Iris E Jansen; Yunpeng Wang; Rahul S Desikan; J Raphael Gibbs; Cornelis Blauwendraat; Wesley K Thompson; Dena G Hernandez; Srdjan Djurovic; Andrew J Schork; Francesco Bettella; David Ellinghaus; Andre Franke; Benedicte A Lie; Linda K McEvoy; Tom H Karlsen; Suzanne Lesage; Huw R Morris; Alexis Brice; Nicholas W Wood; Peter Heutink; John Hardy; Andrew B Singleton; Anders M Dale; Thomas Gasser; Ole A Andreassen; Manu Sharma
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

Review 3.  Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.

Authors:  Mark R Cookson
Journal:  Biochem Soc Trans       Date:  2016-12-15       Impact factor: 5.407

4.  Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity.

Authors:  Nirit Lev; Yael Barhum; Tali Ben-Zur; Eldad Melamed; Israel Steiner; Daniel Offen
Journal:  J Mol Neurosci       Date:  2013-03-28       Impact factor: 3.444

Review 5.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

6.  Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.

Authors:  Rakel Lopez de Maturana; Julio C Aguila; Amaya Sousa; Nerea Vazquez; Patricia Del Rio; Ana Aiastui; Ana Gorostidi; Adolfo Lopez de Munain; Rosario Sanchez-Pernaute
Journal:  Neurobiol Aging       Date:  2013-11-22       Impact factor: 4.673

7.  NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria.

Authors:  Zhenyu Zhong; Atsushi Umemura; Elsa Sanchez-Lopez; Shuang Liang; Shabnam Shalapour; Jerry Wong; Feng He; Daniela Boassa; Guy Perkins; Syed Raza Ali; Matthew D McGeough; Mark H Ellisman; Ekihiro Seki; Asa B Gustafsson; Hal M Hoffman; Maria T Diaz-Meco; Jorge Moscat; Michael Karin
Journal:  Cell       Date:  2016-02-25       Impact factor: 41.582

8.  LRRK2 levels in immune cells are increased in Parkinson's disease.

Authors:  D A Cook; G T Kannarkat; A F Cintron; Laura M Butkovich; Kyle B Fraser; J Chang; N Grigoryan; S A Factor; Andrew B West; J M Boss; M G Tansey
Journal:  NPJ Parkinsons Dis       Date:  2017-03-28

9.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

10.  Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.

Authors:  Jong-Hyeon Kim; Ilo Jou; Eun-Hye Joe
Journal:  Exp Neurobiol       Date:  2014-06-13       Impact factor: 3.261

View more
  44 in total

Review 1.  Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.

Authors:  Michele Goulart Dos Santos; Lucia Emanueli Schimith; Corinne André-Miral; Ana Luiza Muccillo-Baisch; Bruno Dutra Arbo; Mariana Appel Hort
Journal:  Neurotox Res       Date:  2022-01-11       Impact factor: 3.911

2.  Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.

Authors:  Carolyn Tallon; Silvia Picciolini; Seung-Wan Yoo; Ajit G Thomas; Arindom Pal; Jesse Alt; Cristiano Carlomagno; Alice Gualerzi; Rana Rais; Norman J Haughey; Marzia Bedoni; Barbara S Slusher
Journal:  Biochem Pharmacol       Date:  2021-10-20       Impact factor: 5.858

Review 3.  Parkinson's disease and microRNAs - Lessons from model organisms and human studies.

Authors:  Brian Evans; Howard A Furlong; Alexandre de Lencastre
Journal:  Exp Gerontol       Date:  2021-10-08       Impact factor: 4.032

Review 4.  Therapeutic Strategies for Immune Transformation in Parkinson's Disease.

Authors:  Maamoon Saleh; Milica Markovic; Katherine E Olson; Howard E Gendelman; R Lee Mosley
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 5.  Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.

Authors:  Erin John Rieger de Almeida; Hélio Jungkenn Ibrahim; Maria Rosa Chitolina Schetinger; Cinthia Melazzo de Andrade; Andréia Machado Cardoso
Journal:  Neurochem Res       Date:  2022-08-13       Impact factor: 4.414

6.  Microglia-induced autophagic death of neurons via IL-6/STAT3/miR-30d signaling following hypoxia/ischemia.

Authors:  Jun Shu; Xu-Hao Fang; Ya-Jian Li; Yao Deng; Wen-Shi Wei; Li Zhang
Journal:  Mol Biol Rep       Date:  2022-06-02       Impact factor: 2.742

Review 7.  Cellular and molecular pathophysiology in the progression of Parkinson's disease.

Authors:  Vandana Zaman; Donald C Shields; Ramsha Shams; Kelsey P Drasites; Denise Matzelle; Azizul Haque; Narendra L Banik
Journal:  Metab Brain Dis       Date:  2021-02-18       Impact factor: 3.584

8.  A New Tool to Study Parkinsonism in the Context of Aging: MPTP Intoxication in a Natural Model of Multimorbidity.

Authors:  Lorena Cuenca-Bermejo; Elisa Pizzichini; Valeria C Gonçalves; María Guillén-Díaz; Elena Aguilar-Moñino; Consuelo Sánchez-Rodrigo; Ana-María González-Cuello; Emiliano Fernández-Villalba; María Trinidad Herrero
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 9.  Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.

Authors:  Katrina Albert; Jonna Niskanen; Sara Kälvälä; Šárka Lehtonen
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65.

Authors:  Zixuan Lin; Chen Chen; Dongqin Yang; Jianqing Ding; Guanghui Wang; Haigang Ren
Journal:  Cell Death Dis       Date:  2021-07-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.